| nizatidine | <chemical> A histamine h2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers. Pharmacological action: anti-ulcer agents, histamine h2 antagonists. Chemical name: 1,1-Ethenediamine, N-(2-(((2-((dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro- (12 Dec 1998) |
|---|
Synonyms : Axid, LY-139037, N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1, 1-ethenediamine, LY 139037, LY139037
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
³ªÀ̽õåݼ¿150mg - »õâ
|
¿µÀÏÁ¦¾à |
A16651081 | Nizatidine | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ÀÚ´ÏÆ¾Ä°¼¿150mg - »õâ
|
°æµ¿Á¦¾à |
A17650871 | Nizatidine | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾×½Ãµåݼ¿150mg - »õâ
|
Çѱ¹¸±¸® |
B43750081 | Nizatidine | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¾×½Ãµåݼ¿300mg - »õâ
|
Çѱ¹¸±¸® |
B43750091 | Nizatidine | Àü¹®ÀǾàǰ | »èÁ¦ |
|
Å¥·¹½ºÅäݼ¿150mg - »õâ
|
À¯¿µÁ¦¾à |
A34050721 | Nizatidine | Àü¹®ÀǾàǰ | »èÁ¦ |
|
Å¥·¹½ºÅäݼ¿300mg - »õâ
|
À¯¿µÁ¦¾à |
A34050731 | Nizatidine | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¾×»çµòĸ½¶150mg - »õâ
|
±¹Á¦¾àǰ°ø¾÷ |
A03050461 | Nizatidine | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾×½ÃµåÁÖ25mg/ml - »õâ
|
Çѱ¹¸±¸® |
E03070071 | Nizatidine | Àü¹®ÀǾàǰ | »èÁ¦ |
|
ÀÚ´ÏÆ¾Á¤ - »õâ
|
°æµ¿Á¦¾à |
A17603501 | Nizatidine | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ƾÀÚݼ¿150mg - »õâ
|
¼¼Á¾Á¦¾à |
A21150811 | Nizatidine | Àü¹®ÀǾàǰ | ±Þ¿© |
| nizatidine |
[USP] a histamine H2 receptor antagonist, used to inhibit gastric acid secretion in the prophylaxis and treatment of gastric and duodenal ulcers, gastroesophageal reflux disease, and conditions that cause gastric hypersecretion; administered orally.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|